Oncolytics Biotech Inc (ONCY) shareholders
Close on Nov 17, 2026Market cap $48.77MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Anson Funds Management LP Joint filing with Anson Management GP LLC (7.00%), Tony Moore (7.00%) and 3 more | 7,649,050 | 7.00% | 13G (passive) amendment | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ONCY | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Marshall Wace, Llp | 745,350 | 0.58% | $708.08K | −114,481 | 0.00% |
| XTX Topco Ltd | 260,903 | 0.20% | $247.83K | New | 0.00% |
| Seeds Investor LLC | 258,306 | 0.20% | $245.37K | New | 0.03% |
| International Assets Investment Management, LLC | 201,260 | 0.16% | $181.28K | New | 0.01% |
| Connective Capital Management, LLC | 185,712 | 0.15% | $176.41K | New | 0.12% |
| Goldman Sachs Group Inc | 169,898 | 0.13% | $161.39K | New | 0.00% |
| Tocqueville Asset Management L.P. | 147,000 | 0.12% | $139.64K | New | 0.00% |
| Everhart Financial Group, Inc. | 140,899 | 0.11% | $133.84K | New | 0.01% |
| Susquehanna International Group, Llp | 134,129 | 0.11% | $127.41K | New | 0.00% |
| PFG Investments, LLC | 128,300 | 0.10% | $121.87K | New | 0.00% |
| Hrt Financial LP | 126,325 | 0.10% | $119.00K | New | 0.00% |
| Invesco Ltd. | 101,195 | 0.08% | $96.13K | New | 0.00% |
| Doliver Advisors, LP | 100,000 | 0.08% | $94.99K | New | 0.02% |
| LPL Financial LLC | 80,316 | 0.06% | $76.29K | New | 0.00% |
| Franklin Resources Inc | 79,842 | 0.06% | $75.84K | New | 0.00% |
| Cibc World Market Inc. | 69,303 | 0.05% | $65.83K | New | 0.00% |
| Geode Capital Management, LLC | 66,939 | 0.05% | $63.59K | New | 0.00% |
| Renaissance Technologies LLC | 62,010 | 0.05% | $58.90K | New | 0.00% |
| Royal Bank of Canada | 57,411 | 0.05% | $55.00K | New | 0.00% |
| Fifth Third Bancorp | 45,526 | 0.04% | $43.25K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 75 | 4M | 3.1% | 74 / 0 | 1 / 1 | 3M | 0M |
| Q1 2026 | 2 | 1M | 0.7% | 2 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ONCY | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund | 66,939 | 0.05% | $69.62K | 0.00% | May 31, 2026 |
| Victory Extended Market Index Fund | 13,506 | 0.01% | $10.17K | 0.00% | Jul 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -1,300 | -0.00% | -$1.23K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jared Kelly | Chief Executive Officer, Director | 114,050 | 0.09% | Jun 3, 2026 |
| John Bearden McAdory | Chief Operating Officer | – | – | Jun 3, 2026 |
| Kirk Look | Chief Financial Officer | 287,515 | 0.23% | Jun 3, 2026 |
| Allison Hagerman | Chief Technology Officer | 115,059 | 0.09% | Jun 3, 2026 |
| Thomas Charles Heineman | Chief Medical Officer | 282,818 | 0.22% | Jun 3, 2026 |
| Andrew Aromando | Chief Business Officer | 55,100 | 0.04% | Jun 3, 2026 |
| Deborah Margaret Brown | Director | 109,851 | 0.09% | Jun 3, 2026 |
| Stephen C. Glover | Director | – | – | Jun 3, 2026 |
| Angela Holtham | Director | 183,639 | 0.14% | Jun 3, 2026 |
| Jonathan Rigby | Director | 42,728 | 0.03% | Jun 3, 2026 |
| Wayne Pisano | Director | 492,414 | 0.39% | Jun 3, 2026 |
| James T. Parsons | Director | 41,849 | 0.03% | Jun 3, 2026 |
| Bernd R. Seizinger | Director | 566,991 | 0.44% | Jun 3, 2026 |
| Patricia S. Andrews | Director | 78,128 | 0.06% | Jun 3, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jared Kelly Chief Executive Officer, Director | Mar 12, 2026 | Buy | +5,050 | $0.96 | $4.85K | 114,050 |
| James T. Parsons Director | Mar 11, 2026 | Buy | +10,000 | $1.03 | $10.30K | 41,849 |
| Thomas Charles Heineman Chief Medical Officer | Feb 12, 2026 | Buy | +12,132 | $0.83 | $10.07K | 282,818 |
| Wayne Pisano Director | Feb 12, 2026 | Buy | +30,000 | $0.84 | $25.20K | 492,414 |
| Allison Hagerman VP, Product Development | Feb 12, 2026 | Buy | +10,000 | $0.83 | $8.30K | 115,059 |
| Bernd R. Seizinger Director | Feb 12, 2026 | Buy | +40,000 | $0.85 | $34.00K | 566,991 |
| Jared Kelly Chief Executive Officer, Director | Feb 12, 2026 | Buy | +29,500 | $0.84 | $24.78K | 109,000 |
| Patricia S. Andrews Director | Feb 12, 2026 | Buy | +35,400 | $0.86 | $30.44K | 78,128 |
| Kirk Look Chief Financial Officer | Feb 12, 2026 | Buy | +12,000 | $0.84 | $10.08K | 287,515 |
| Deborah Margaret Brown Director | Feb 12, 2026 | Buy | +25,000 | $0.85 | $21.25K | 109,851 |
| Andrew Aromando Chief Business Officer | Feb 11, 2026 | Buy | +29,600 | $0.86 | $25.46K | 55,100 |
| Bernd R. Seizinger Director | Feb 11, 2026 | Buy | +60,000 | $0.83 | $49.80K | 526,991 |
| Jared Kelly Chief Executive Officer, Director | Feb 11, 2026 | Buy | +5,600 | $0.84 | $4.70K | 79,500 |
| Bernd R. Seizinger Director | Jan 16, 2026 | Buy | +100,000 | $1.04 | $104.00K | 466,991 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Oncolytics Biotech's stock actually held short. Settlement fails (shares not delivered on time) peaked at 81,223 shares on Oct 14, 2026 over the last 90 days.
See a number that looks wrong?